Khalil Hassan A, Shi Weiwei, Mazzola Emanuele, Lee Daniel Nahum, Norton-Hughes Emily, Dolan Daniel, Corman Samantha, White Abby, Sholl Lynette M, Swanson Scott J
Division of Thoracic and Cardiac Surgery, Department of Surgery, Brigham and Women's Hospital, Boston, Mass.
Thoracic Pathology, Department of Pathology, Brigham and Women's Hospital, Boston, Mass.
J Thorac Cardiovasc Surg. 2023 Nov;166(5):1317-1328.e4. doi: 10.1016/j.jtcvs.2023.01.030. Epub 2023 Feb 16.
Spread through air spaces is defined as tumor cells in air spaces away from the edge of tumor in lung carcinoma. It is associated with higher locoregional recurrence and lower survival in lung adenocarcinoma. The features of spread through air spaces portending worse outcomes are still under investigation. We reviewed our lung cancer experience to define potential factors related to spread through air spaces that influence recurrence and survival.
Between January 2010 and December 2017, we identified 968 patients who underwent resection for T1-3N0M0 lung adenocarcinoma. Of these, histologic examination was possible in 787 patients. We examined the presence of spread through air spaces, spread through air spaces characteristics (micropapillary, solid nest, or single cell), average density (number per slide), and farthest distance from tumor at which spread through air spaces was detected, or maximal spread distance. Overall survival and recurrence-free survival were estimated using Kaplan-Meier curves, and differences between spread through air spaces positive versus spread through air spaces negative groups were assessed using the log-rank test.
Spread through air spaces was present in 389 of 787 of the reviewed cases (49.4%). Overall survival and recurrence-free survival were significantly lower in the spread through air spaces positive group over 10 years (P < .0001). The incidences of locoregional and distant recurrence were nearly doubled over 10 years in the spread through air spaces positive group compared with the spread through air spaces negative group (P = .002 and <.0001, respectively). In a multivariable Cox regression model adjusted for spread through air spaces characteristics, distance, and tumor size, lobar resection did not confer survival advantage in patients with spread through air spaces (hazard ratio of sublobar resection with respect to lobar resection, 1.44; 95% confidence interval, 0.98-2.11; P = .067). In the spread through air spaces positive group, spread through air spaces density was 2.7 ± 1.4 clusters per slide and the maximal spread distance was 2.2 ± 1.7 mm from the tumor edge. There was no observed correlation between spread through air spaces density or maximal spread distance and overall survival or recurrence.
We show increased distant recurrence in spread through air spaces positive lung adenocarcinoma. Quantifiable measures of spread through air spaces do not appear to correlate with recurrence or survival metrics.
气腔播散定义为肺癌中肿瘤细胞出现在远离肿瘤边缘的气腔内。它与肺腺癌较高的局部区域复发率和较低的生存率相关。气腔播散预示更差预后的特征仍在研究中。我们回顾了我们治疗肺癌的经验,以确定与气腔播散相关的、影响复发和生存的潜在因素。
在2010年1月至2017年12月期间,我们确定了968例行T1-3N0M0肺腺癌切除术的患者。其中,787例患者可行组织学检查。我们检查了气腔播散的存在情况、气腔播散特征(微乳头、实性巢状或单细胞)、平均密度(每张切片中的数量)以及检测到气腔播散的距肿瘤最远的距离,即最大播散距离。采用Kaplan-Meier曲线估计总生存期和无复发生存期,并使用对数秩检验评估气腔播散阳性组和气腔播散阴性组之间的差异。
在787例回顾病例中,389例(49.4%)存在气腔播散。气腔播散阳性组10年的总生存期和无复发生存期显著更低(P <.0001)。与气腔播散阴性组相比,气腔播散阳性组10年的局部区域复发和远处复发发生率几乎翻倍(分别为P = 0.002和<0.0001)。在调整了气腔播散特征、距离和肿瘤大小的多变量Cox回归模型中,叶切除术在气腔播散患者中未显示出生存优势(亚叶切除术相对于叶切除术的风险比为1.44;95%置信区间为0.98-2.11;P = 0.067)。在气腔播散阳性组中,气腔播散密度为每张切片2.7±1.4个簇,最大播散距离距肿瘤边缘2.2±1.7mm。未观察到气腔播散密度或最大播散距离与总生存期或复发之间的相关性。
我们发现气腔播散阳性的肺腺癌远处复发增加。气腔播散的可量化指标似乎与复发或生存指标无关。